Anuh Pharma Ltd.
| BSE: 506260 | Sector: Health care |
| NSE: N.A. | ISIN Code: INE489G01022 |
| BSE 00:00 | 18 May | 98.90 |
-2.00 (-1.98%) |
OPEN
102.75 |
HIGH
102.75 |
LOW
98.35 |
| NSE 05:30 | 01 Jan | Anuh Pharma Ltd |
| OPEN | 102.75 |
| PREVIOUS CLOSE | 100.90 |
| VOLUME | 21397 |
| 52-Week high | 156.00 |
| 52-Week low | 84.60 |
| P/E | 16.21 |
| Mkt Cap.(Rs cr) | 496 |
| Buy Price | 0.00 |
| Buy Qty | 0.00 |
| Sell Price | 0.00 |
| Sell Qty | 0.00 |
Anuh Pharma Ltd. (ANUHPHARMA) - Net Sales
Market Cap
| COMPANY | LATEST(Rs) | CHG | CHG(%) | Net Sales (Rs crore) |
| Aurobindo Pharma | 559.45 | 23.40 | 4.37 | 15823.68 |
| Cipla | 957.90 | 19.90 | 2.12 | 13900.58 |
| Dr Reddy's Labs | 3908.10 | 4.00 | 0.10 | 13349.10 |
| Sun Pharma.Inds. | 899.40 | 7.35 | 0.82 | 12803.21 |
| Lupin | 683.25 | -8.15 | -1.18 | 11055.93 |
| Apollo Hospitals | 3737.00 | -75.85 | -1.99 | 9153.00 |
| Zydus Lifesci. | 347.15 | -1.90 | -0.54 | 7790.40 |
| Glenmark Pharma. | 406.10 | 3.85 | 0.96 | 7567.93 |
| Alkem Lab | 2941.60 | 37.90 | 1.31 | 7219.68 |
| Divi's Lab. | 4365.60 | 63.35 | 1.47 | 6798.61 |
| Torrent Pharma. | 2639.15 | 21.40 | 0.82 | 6450.83 |
| Ipca Labs. | 990.45 | 1.70 | 0.17 | 5114.11 |
| Alembic Pharma | 749.90 | 2.30 | 0.31 | 5051.44 |
| Laurus Labs | 566.60 | 7.50 | 1.34 | 4768.72 |
| Abbott India | 17860.75 | 225.05 | 1.28 | 4310.02 |
| Gland Pharma | 3105.10 | -0.35 | -0.01 | 3462.88 |
| Glaxosmi. Pharma | 1526.10 | 8.90 | 0.59 | 3193.74 |
| Granules India | 263.05 | 12.55 | 5.01 | 3134.98 |
| Sanofi India | 6651.90 | 49.50 | 0.75 | 2956.60 |
| Ajanta Pharma | 1701.05 | -5.35 | -0.31 | 2718.59 |
Quick Links for Anuh Pharma:
-
News
Announcements Brokerage Reports Business Earnings Sector -
Corporate Action
AGM Board Meetings Bonus Dividends EGM Rights Split -
INFORMATION
Bulk Deals Company History MF Holding Listing Info Locations Shareholding -
Financials
Financial Overview Balance Sheet Profit & Loss Cash Flow Ratios Quarterly Results Half Yearly Results Nine Monthly Results Yearly Results -
Annual Report
Auditors Report Chairman's Speech Company Management Directors' Report Finished Goods Raw Materials -
Peer Comparison
Competition Market Cap Price Price Performance Net Sales Net Profit Total Assets Historical Prices
